SANMIT INFRA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.85 INR | +2.00% |
|
+10.32% | -61.86% |
| Sales 2022 | 1.46B 17.56M | Sales 2023 | 1.4B 16.78M | Capitalization | 10.94B 131M |
|---|---|---|---|---|---|
| Net income 2022 | 64M 768K | Net income 2023 | 51M 612K | EV / Sales 2022 | 4.38 x |
| Net Debt 2022 | 82.64M 991K | Net Debt 2023 | 80.46M 965K | EV / Sales 2023 | 7.88 x |
| P/E ratio 2022 |
86.5
x | P/E ratio 2023 |
212
x | Employees | - |
| Yield 2022 |
0.09% | Yield 2023 |
0.05% | Free-Float | 17.74% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.00% | ||
| 1 week | +10.32% | ||
| Current month | +64.82% | ||
| 1 month | +56.58% | ||
| 3 months | -34.76% | ||
| 6 months | -75.14% | ||
| Current year | -61.86% |
1 week
16.50
17.85
1 month
10.2917.85
Current year
10.2948.18
1 year
10.2994.74
3 years
7.8194.74
5 years
2.6094.74
10 years
1.2594.74
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | 14/15/14 | |
| Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director/Board Member | 55 | 12/15/12 | |
| Director of Finance/CFO | - | 14/15/14 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 17.85 | +2.00% | 118,298 |
| 25/24/25 | 17.5 | +1.98% | 32,384 |
| 24/24/24 | 17.16 | +1.96% | 21,579 |
| 23/24/23 | 16.83 | +2.00% | 36,403 |
| 22/24/22 | 16.5 | +1.98% | 40,087 |
Delayed Quote Bombay S.E., April 26, 2024 at 03:30 pm IST
More quotes
Sanmit Infra Limited is an India-based company. The Companyâs segments include Realty and Infrastructure, Petroleum and related products, Biomedical Waste recycling machinery and other equipment and Bitumen emulsion and other road construction related materials. The Company is mainly in the business of biomedical and other waste management; infra and real estate development, and trading in petroleum products. It covers a range of individual and corporate accounting services, such as biomedical waste, infrastructure, and petroleum. Its biomedical waste treatment section consists of ultraviolet germicidal irradiation (UVGI) process; high frequency high temperature disinfection (HFHTD), and process temperature maintenance (TM) process. It offers a variety of petroleum products consisting of lubricants, public distribution system (PDS) kerosene, furnace oil, light diesel oil, base oil, and bitumen. The Company is engaged in constructing residential and commercial complexes.
Calendar
29/05/2024
- Q4 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -61.86% | 33.82M | |
| -5.24% | 5.86B | |
| 0.00% | 4.55B | |
| -12.67% | 3.91B | |
| -1.43% | 3.56B | |
| +23.40% | 3.23B | |
| +8.47% | 1.95B | |
| +11.60% | 1.6B | |
| +1.01% | 1.38B | |
| +0.07% | 1.1B |
- Stock Market
- Equities
- SANINFRA Stock
